Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001209191-22-043769

Chief Scientific Officer acquired 118,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kidron Miriam Chief Scientific Officer 2022-07-28 Grant or award +34,000 217,666 D
Kidron Miriam Chief Scientific Officer 2022-07-28 Grant or award +84,000 301,666 D
Loading xslF345X03/doc4.xml…